Plasma endothelin-1, homocysteine and serum nitric oxide values in patients with left-to-right shunt
- PMID: 15751522
Plasma endothelin-1, homocysteine and serum nitric oxide values in patients with left-to-right shunt
Abstract
Background: This study aimed to evaluate the effect of pulmonary blood flow and pulmonary hypertension on plasma endothelin-1, homocysteine and serum nitric oxide levels in patients with left-to-right shunt lesions with pulmonary hypertension and also with normal pulmonary arterial pressure.
Methods and results: Plasma endothelin-1, homocysteine and nitric oxide levels were measured in 44 patients (Group 1) with left-to-right shunt and normal pulmonary arterial pressure (Qp/Qs: 2.1), 65 patients (Group 2) with left-to-right shunt and pulmonary hypertension (Qp/Qs: 2.4), 20 healthy control subjects (Group 3), and 17 post-operative patients (Group 4). Plasma endothelin-1 and serum nitric oxide levels were significantly higher in Group 2 than in groups 1, 3, and 4 (p<0.001). Plasma homocysteine levels were significantly higher in Group 2 than in Groups 1 and 4 (p<0.001 and p<0.01, respectively).
Conclusions: The increase in serum nitric oxide levels in patients with left-to-right shunt and pulmonary hypertension may be attributed to the compensatory mechanism. However, this increase does not improve pulmonary hypertension because of increased endothelin-1 and homocysteine levels. In the light of present study, we conclude that vascular changes caused by increased homocysteine and endothelin-1 may provoke pulmonary hypertension in patients with left-to-right shunt.
Similar articles
-
Plasma levels of nitric oxide in children with congenital heart disease and increased pulmonary blood flow.J Med Assoc Thai. 2007 Oct;90(10):2053-7. J Med Assoc Thai. 2007. PMID: 18041423
-
Metabolites of the L-arginine-NO pathway in patients with left-to-right shunt.Clin Lab. 2001;47(9-10):441-7. Clin Lab. 2001. PMID: 11596905
-
Dynamic changes of endothelin-1, nitric oxide, and cyclic GMP in patients with congenital heart disease.Circulation. 1997 Nov 4;96(9 Suppl):II-346-51. Circulation. 1997. PMID: 9386122
-
[Pulmonary arterial hypertension. Part I: pathobiologic, pathophysiologic, clinical and diagnostic aspects].G Ital Cardiol (Rome). 2009 May;10(5):271-300. G Ital Cardiol (Rome). 2009. PMID: 19537440 Review. Italian.
-
[Vasodilatator testing with nitric oxide (bronchial control treatment system--BCTS) in patients with pulmonary hypertension].Przegl Lek. 2004;61(6):737-42. Przegl Lek. 2004. PMID: 15724676 Review. Polish.
Cited by
-
Advances in diagnosis and treatment of pulmonary arterial hypertension in neonates and children with congenital heart disease.World J Pediatr. 2010 Feb;6(1):13-31. doi: 10.1007/s12519-010-0002-9. Epub 2010 Feb 9. World J Pediatr. 2010. PMID: 20143207 Review.
-
Comment on an article: "High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia".Med Hypotheses. 2020 Dec;145:110338. doi: 10.1016/j.mehy.2020.110338. Epub 2020 Oct 7. Med Hypotheses. 2020. PMID: 33049593 Free PMC article. No abstract available.
-
Novel biomarkers for pulmonary arterial hypertension.Respir Res. 2016 Jul 20;17(1):88. doi: 10.1186/s12931-016-0396-6. Respir Res. 2016. PMID: 27439993 Free PMC article. Review.
-
Elevated homocysteine and asymmetric dimethyl arginine levels in pulmonary hypertension associated with congenital heart disease.Pediatr Cardiol. 2012 Dec;33(8):1323-31. doi: 10.1007/s00246-012-0321-9. Epub 2012 Apr 21. Pediatr Cardiol. 2012. PMID: 22526220
MeSH terms
Substances
LinkOut - more resources
Medical